Measurement properties of the Fear-Avoidance Belief Questionnaire for physical activity in patients with shoulder impingement syndrome

肩峰撞击综合征患者身体活动恐惧回避信念问卷的测量特性

阅读:1

Abstract

BACKGROUND: The Fear-Avoidance Belief Questionnaire for physical activity (FABQ-PA) was originally developed for patients with low-back pain. Whether the FABQ-PA is suitable for use among patients with other musculoskeletal disorders has been sparsely evaluated. PURPOSE: To evaluate test-retest reliability, measurement error, construct validity, and responsiveness of the FABQ-PA in patients with shoulder impingement syndrome (SIS). METHODS: This prospective cohort study included 45 patients with SIS. Data were collected with questionnaires at baseline, after 2-4 days, and at 3 months, which included the Danish versions of the FABQ-PA and the Oxford Shoulder Score (OSS). Test-retest reliability was assessed by intraclass correlation, and standard error of measurement was estimated and converted into the minimal detectable change (MDC). Construct validity was investigated by analyzing the correlation between the baseline scores of the FABQ-PA and the OSS. Responsiveness was investigated from longitudinal construct validity using a correlation analysis reflecting changes over time. RESULTS: Test-retest reliability showed an intraclass correlation of 0.80, and examination of the measurement error showed no systematic differences and a MDC of 7.95 (95% CI 6.57-10.07). Construct validity showed a correlation of -0.60 (95% CI -0.76 to -0.37) between the FABQ-PA and OSS at baseline. A weaker correlation between FABQ-PA- and OSS-change scores was observed (-0.43, 95% CI -0.67 to -0.12). CONCLUSION: The Danish version of the FABQ-PA is suitable for assessing fear-avoidance beliefs in groups of patients with SIS, but its ability to evaluate individual patients and changes over time may be more limited.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。